Arcellx, Inc. vs Johnson & Johnson
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $6.7 B for Arcellx, Inc., 98 times as much (market caps of Mar 8, 2026 for Arcellx, Inc. and Oct 29, 2026 for Johnson & Johnson). Arcellx, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Arcellx, Inc. ACLX | Johnson & Johnson JNJ · #24 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | — | Pharmaceutical |
| Founded | 2014 | 1886 |
| Size | ||
| Market cap | $6.7 B* | $652.5 B |
| Revenue | — | $94.2 B |
| Net income | — | $26.8 B |
| Employees | — | 138,200 |
| Valuation | ||
| P/E ratio | — | 40.5× |
| Price to sales | — | 6.6× |
| Price to book | — | 8.0× |
| Free cash flow yield | — | 3.0% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Mar 2026 | Market cap Oct 2026 |
Questions and answers#
Which is bigger, Arcellx, Inc. or Johnson & Johnson?
Johnson & Johnson is the larger company by market value: $652.5 B against $6.7 B for Arcellx, Inc., 98 times as much (market caps of Mar 8, 2026 for Arcellx, Inc. and Oct 29, 2026 for Johnson & Johnson). Arcellx, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.